Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEDI-NAD Trial: Injectable NAD⁺ for Pediatric Cardiac Dysfunction
NCT07839130Phase 2Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide adenine dinucleotide in Cardiac dysfunction, sponsored by Beijing Children's Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
nicotinamide adenine dinucleotide
03
Conditions
Cardiac dysfunction
Beyond the preview
Go deeper on NCT07839130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07839130.